Nakagawa, Junichi
Kinjo, Takahiko
Aiuchi, Naoya
Ueno, Kayo
Tomita, Hirofumi
Niioka, Takenori https://orcid.org/0000-0002-4560-6423
Article History
Received: 16 May 2022
Accepted: 11 November 2022
First Online: 18 November 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethics Committee of Hirosaki University Graduate School of Medicine (project identification code: 2018–011-02) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in this study.
: Not applicable.
: Dr. Tomita received research funding from Boehringer Ingelheim, Bayer, and Daiichi-Sankyo and speakers’ bureau/honoraria from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo and Pfizer. Dr Niioka received speakers’ honoraria from Daiichi-Sankyo. The remaining authors have nothing to disclose.